See inside every stock. Pro
WatchlistPro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI100.02▲ 2.95%

ARK Genomic Revolution (ARKG)

Healthcare ETF · ARK Invest · BATS · 33 holdings
$47.87 ▼ -1.98 (3.97%)
At close · USD · Volume 7,340,262
Returns and riskCostIncomeDividend historyHoldingsQuestions
52-week range
$24.60 – $58.83
Day's range
$46.83 – $49.91
1-year total return
+56.6%
This fund is also covered on our sister site ETFWinner.com, which has screener, overlap and comparison tools for ETFs.

ARKG price chart

Daily, split-corrected, distributions markedEnd-of-day prices

ARKG fund facts

FundARK Genomic Revolution ETF
TickerARKG · BATS
Issuer (by our rules)ARK Invest
Category (by our rules)Healthcare
Expense ratio0.75%
Holdings33
Net assets (fund, SEC)$1.6B
Yield (last 12 months)No distributions
DistributionsAnnual
52-week range$24.60 – $58.83
Average volume (3 months)4,352,551
First price in our data31 Oct 2014
Issuer and category are assigned by StocksXray rules from the fund name. Expense ratio and net assets come from SEC filings; where a fund does not file them (for example grantor trusts) the field stays empty.

Returns and risk

1 month
−9.5%
3 months
+23.2%
6 months
+55.0%
Year to date
+65.2%
1 year
+56.6%
3 years a year
+26.3%
5 years a year
−8.4%
10 years a year
+11.3%
Volatility (1 year)
44.8%
Largest drop, last year
−27.5%
Largest drop in our data
−83.6%
Total return includes distributions, from end-of-day prices adjusted for splits and distributions, to 22 Oct 2026. Periods of 3 years and longer are annualised and shown only when the fund's history is long enough. Volatility is the standard deviation of daily returns over the last year, annualised. Past performance does not guarantee future results.

Cost: expense ratio

0.75% a year

On $10,000 invested that is about $75 a year in fund costs, taken out of the fund's assets.

Source: the fund's prospectus, as filed with the SEC on 26 Nov 2025 (risk/return summary data). Brokerage commissions and the bid-ask spread are separate costs.

Income: distributions

ARKG paid no distributions in the last 12 months. Its return comes from price change only.

Cash paid per current share (restated for share splits), before tax, from EODHD.

ARKG top holdings

#HoldingWeight
1 10X GENOMICS INC 9.39%
2 TWIST BIOSCIENCE CORP 7.73%
3 TEMPUS AI INC 6.56%
4 CRISPR THERAPEUTICS AG 6.29%
5 PERSONALIS INC 5.47%
6 ABSCI CORP 5.14%
7 GUARDANT HEALTH INC 4.74%
8 ILLUMINA INC ILMN 4.74%
9 ELI LILLY & COMPANY LLY 4.68%
10 CAREDX INC 4.30%
The top 10 make up 59.1% of the fund, out of 33 holdings.
Positions as of 31 Jul 2026, from the fund's Form N-PORT filed with the SEC. Public N-PORT holdings are quarter-end positions published about 60 days later, so they can be months old and the fund may have changed since.

Similar Healthcare ETFs

IBB iShares Biotechnology0.44% fee · +36.4% 1y IHI iShares U.S. Medical Devices0.38% fee · −11.3% 1y XBI SPDR S&P Biotech0.35% fee · +41.9% 1y XLV Health Care Select Sector SPDR0.08% fee · +26.3% 1y IYH iShares U.S. Healthcare0.38% fee · +25.6% 1y IHF iShares U.S. Healthcare Provid...0.38% fee · +20.6% 1y All healthcare ETFs →
Funds of the same category, nearest in trading size. Similar does not mean equivalent: check holdings and costs.

ARKG: frequently asked questions

What is ARKG?

ARKG is the ARK Genomic Revolution ETF, issued by ARK Invest, listed on BATS. By our rules it is classed as "Healthcare". Its latest SEC filing lists 33 holdings.

What is the expense ratio of ARKG?

ARKG charges 0.75% a year, according to its prospectus filed with the SEC on 26 Nov 2025. On $10,000 that is about $75 a year in fund costs.

Does ARKG pay dividends?

No. We found no distributions for ARKG in the last 12 months.

What does ARKG hold?

The largest holdings in the latest SEC filing are 10X GENOMICS INC (9.4%), TWIST BIOSCIENCE CORP (7.7%), TEMPUS AI INC (6.6%). The top 10 together make up 59.1% of the fund.

How has ARKG performed?

Total return including distributions to 22 Oct 2026: 1 year +56.6%, 3 years +26.3% a year, 5 years −8.4% a year. Past performance does not guarantee future results.

Where the numbers come from

Prices and distributions end-of-day data from EODHD; returns are our own calculations from it.
Expense ratio and holdings SEC filings (prospectus risk/return data and Form N-PORT).
Category, issuer and leverage assigned by StocksXray rules from the fund name.
X-Ray look-through our scores applied to the SEC holdings.
Read the methodology →

StocksXray is for education only and is not financial advice or a recommendation to buy or sell anything. Past performance does not guarantee future results; funds can lose value.